Skip to main content
Equibles
PMVP logo

PMVP · PMV Pharmaceuticals, Inc. · Holdings

Track PMVP — free

Use PMVP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PMVP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.25 +0.12 (+10.62%) At close · Oct 27
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Management has determined that the Company's current available cash, cash equivalents and marketable securities may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$60.41M
Shares
53.46M
Volume · Oct 27 375.17K Avg daily vol (3M) 670.74K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of PMVP: 13F, 13D and 13G, insiders and funds →
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 64
Total Value: $46,352,911
Total Shares: 34,498,479

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 64 13F filers
Top Holder
15.4%
Sep 2023 → Jun 2026 · range 11.9% – 18.7%
of institutional value
Top 5
49.8%
Sep 2023 → Jun 2026 · range 38.8% – 60.6%
of institutional value
Top 10
78.9%
Sep 2023 → Jun 2026 · range 60.3% – 85.3%
of institutional value
HHI
746
Sep 2023 → Jun 2026 · range 481 – 965
Broadly held

Who Holds PMVP

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 64 filers, like-for-like change -7.3%; actively managed books -5.4%; index-like books -16.4%.

Holder type Share Filers Change
Registered adviser 37.6% 27 -7.3%
Exempt adviser 16.5% 2 -1.8%
Adviser 9.0% 2 -13.0%
Bank 1.8% 9 -3.6%
Broker-dealer 0.0% 1 0.0%
Benefit plan 0.0% 1 -48.3%
Non-US 1.2% 2 +228.8%
Holding company 3.2% 3 -40.7%
Unknown 30.6% 17 -5.4%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

64 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
2
3.13% of filers hold it in their top 10
Mar 31, 2026: 2
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
36.5%
of shares outstanding, 89th percentile
Mar 31, 2026: 40.2%
Private-fund advisers
29.9%
of shares outstanding
Institutional ownership
64.3%
66.0% of the estimated free float
Top 10 holders
79.4%
of 13F shares, Herfindahl 0.076
Active holders
-5.4%
like-for-like share change of active filers
5% stakes on record
2
0 13D, 2 13G (0 institutional, 2 passive, 0 exempt)
How long holders have held it value-weighted 10.0 quarters
Under 1 year 22.8% 1 to 3 years 52.0% 3 years or more 25.3% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $0 (0 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$1.64
estimated per share
Mar 31, 2026: $1.64
Quarter-end price
$1.34
implied by 13F values
Estimated gain or loss
-18.3%
price against the estimated cost
Estimated at a loss
78.1%
of costed 13F value

Estimated cost covers 74.5% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies PMVP's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 AVIR Atea Pharmaceuticals, Inc. 3
2 IDYA IDEAYA Biosciences, Inc. 5
3 PLRX Pliant Therapeutics, Inc. 4
4 ANTX AN2 Therapeutics, Inc. 3
5 SVRA Savara Inc 5
6 OKUR OnKure Therapeutics, Inc. 4
7 DNTH Dianthus Therapeutics, Inc. 6
8 FULC Fulcrum Therapeutics, Inc. 3
9 CTMX CytomX Therapeutics, Inc. 4
10 CRBP Corbus Pharmaceuticals Holdings, Inc. 3

Shareholder Targets

13F filers that own its peers but not PMVP, quarter ended Jun 30, 2026

Found through its holder-overlap peers: AVIR, IDYA, PLRX, ANTX, SVRA, OKUR, DNTH, FULC, CTMX, CRBP, EDIT, CELC, RCKT, ALEC, SRZN, VIR, ACRS, DRUG, TYRA, CTNM. 722 filers in all.

# Filer In peers
1 FMR LLC Holding company, Diversified active $1,895,264,975 20 held
2 BAKER BROS. ADVISORS LP Registered adviser, Concentrated $1,116,954,807 6 held
3 Jupiter Topco LLC Unknown, Diversified active $604,192,576 9 held
4 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $531,682,230 19 held
5 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $522,564,647 5 held
6 RTW INVESTMENTS, LP Registered adviser, Diversified active $480,903,851 5 held
7 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $467,885,894 13 held
8 TCG Crossover Management, LLC Unknown, Diversified active $437,687,879 6 held
9 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $407,298,319 4 held
10 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $379,116,617 2 held

Fund Ownership of PMVP by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.83% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.90% 479,996
Index ETFs 3.93% 2,099,954
Active ETFs 0.00% 0
Active funds 3.07% 1,639,516
Unclassified 0.03% 17,953
All registered funds 7.93% 4,237,419
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Holder type: Registered adviser 27 Exempt adviser 2 Adviser 2 Bank 9 Broker-dealer 1 Benefit plan 1 Non-US 2 Holding company 3 Unknown 17
Showing 66 of 66
All Common Calls Puts
Export CSV
Holder Value (USD) % of 13F Shares Open
BML Capital Management, LLC $7,142,200 15.41% 5,330,000
TANG CAPITAL MANAGEMENT LLC $5,688,413 12.27% 4,245,085
Sio Capital Management, LLC $3,529,743 7.61% 2,634,137
Euclidean Capital LLC $3,521,041 7.60% 2,627,643
ADAGE CAPITAL PARTNERS GP, L.L.C. $3,162,400 6.82% 2,360,000
ACADIAN ASSET MANAGEMENT LLC $2,969,297 6.41% 2,215,894
VANGUARD CAPITAL MANAGEMENT LLC $2,696,106 5.82% 2,012,020
ArrowMark Colorado Holdings LLC $2,625,835 5.66% 1,959,579
TWO SIGMA INVESTMENTS, LP $2,618,542 5.65% 1,954,136
Eversept Partners, LP $2,533,811 5.47% 1,890,904
BlackRock, Inc. $1,232,555 2.66% 919,818
Stonepine Capital Management, LLC $718,355 1.55% 536,086
GEODE CAPITAL MANAGEMENT, LLC $634,031 1.37% 473,158
Aldebaran Capital, LLC $626,358 1.35% 467,432
BRIDGEWAY CAPITAL MANAGEMENT, LLC $574,663 1.24% 428,853
Assenagon Asset Management S.A. $549,002 1.18% 328,744
BIT Capital GmbH $546,123 1.18% 407,555
Verdad Advisers, LP $485,563 1.05% 362,361
Walleye Capital LLC $449,829 0.97% 335,694
MARSHALL WACE, LLP $430,956 0.93% 321,610
VANGUARD FIDUCIARY TRUST CO $341,398 0.74% 254,775
BANK OF AMERICA CORP /DE/ $321,747 0.69% 240,110
CITADEL ADVISORS LLC $271,082 0.58% 202,300
ADAR1 Capital Management, LLC $269,350 0.58% 201,008
STATE STREET CORP $245,458 0.53% 183,178
RBF Capital, LLC $217,348 0.47% 162,200
GOLDMAN SACHS GROUP INC $183,571 0.40% 136,994
MAI Capital Management $178,383 0.38% 133,122
Rangeley Capital, LLC $132,981 0.29% 99,240
NORTHERN TRUST CORP $124,682 0.27% 93,047
Ikarian Capital, LLC $119,442 0.26% 89,136
JACOBS LEVY EQUITY MANAGEMENT, INC $94,475 0.20% 70,504
PNC FINANCIAL SERVICES GROUP, INC. $91,035 0.20% 67,938
Accurate Wealth Management, LLC $83,500 0.18% 50,000
Quadrature Capital Ltd $83,173 0.18% 62,070
Seven Fleet Capital Management LP $71,782 0.15% 53,569
HRT FINANCIAL LP $67,683 0.15% 50,510
CITADEL ADVISORS LLC $63,392 0.14% 47,308
MORGAN STANLEY $55,855 0.12% 41,684
JANE STREET GROUP, LLC $53,876 0.12% 40,207
ALGERT GLOBAL LLC $53,403 0.12% 39,853
COOPER/HAIMS ADVISORS, LLC $52,288 0.11% 39,021
SUSQUEHANNA INTERNATIONAL GROUP, LLP $50,291 0.11% 37,531
Connor, Clark & Lunn Investment Management Ltd. $43,496 0.09% 32,460
Squarepoint Ops LLC $42,656 0.09% 31,833
HSBC HOLDINGS PLC $41,393 0.09% 30,891
BARCLAYS PLC $37,199 0.08% 27,761
BOOTHBAY FUND MANAGEMENT, LLC $36,348 0.08% 27,126
Vanguard Global Advisers, LLC $28,889 0.06% 21,559
CITIGROUP INC $25,856 0.06% 19,296
Pathstone Holdings, LLC $23,432 0.05% 17,487
JANE STREET GROUP, LLC $22,244 0.05% 16,600
Corient Private Wealth LLC $20,100 0.04% 15,000
Sand Hill Global Advisors, LLC $16,802 0.04% 12,539
Independent Advisor Alliance $16,750 0.04% 12,500
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO $13,668 0.03% 10,200
DEERFIELD MANAGEMENT COMPANY, L.P. $11,778 0.03% 8,790
Silver Grove Financial Group, Inc. $6,809 0.01% 5,082
Tower Research Capital LLC (TRC) $1,425 0.00% 1,064
JONES FINANCIAL COMPANIES LLLP $1,340 0.00% 1,000
BNP PARIBAS ARBITRAGE, SA $694 0.00% 518
UBS Group AG $483 0.00% 361
JPMORGAN CHASE & CO $286 0.00% 214
GROUP ONE TRADING LLC $120 0.00% 90
ROYAL BANK OF CANADA $101 0.00% 76
Caitong International Asset Management Co., Ltd $24 0.00% 18
Key facts CIK 1699382 CUSIP 69353Y103 13F (30d) 2 filings 2 filers Visit website Investor relations